Acid-Base and Potassium Disorders in Liver Disease

Seminars in Nephrology

Volumn 26, Issue 6, 2006, Pages 466-470

  Ahya, Shubhada N ^a   José Soler, Maria ^a   Levitsky, Josh ^a   Batlle, Daniel ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

acid base; hyperkalemia; kidney; liver disease; liver failure; metabolic acidosis; respiratory alkalosis

Indexed keywords

AMILORIDE; ANGIOTENSIN II ANTAGONIST; CHLOROTHIAZIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPLERENONE; LOOP DIURETIC AGENT; POTASSIUM SPARING DIURETIC AGENT; SPIRONOLACTONE; TERLIPRESSIN; THIAZIDE DIURETIC AGENT; TRIAMTERENE;

AMYLOIDOSIS; ANION GAP; ARTICLE; AUTOIMMUNE DISEASE; BLOOD GAS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISORDERS OF ACID BASE BALANCE; FANCONI RENOTUBULAR SYNDROME; GLYCOGEN STORAGE DISEASE; HEAVY METAL POISONING; HEMODYNAMICS; HEPATIC COMA; HEPATIC ENCEPHALOPATHY; HUMAN; HYPERCHLOREMIC ACIDOSIS; HYPERKALEMIA; HYPOKALEMIA; KIDNEY DISTAL TUBULE; KIDNEY DYSFUNCTION; KIDNEY TUBULE ACIDOSIS; LIVER DISEASE; LIVER DYSFUNCTION; LIVER METABOLISM; METABOLIC ACIDOSIS; METABOLIC ALKALOSIS; POTASSIUM DEFICIENCY; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RESPIRATORY ALKALOSIS; SODIUM TRANSPORT; URINALYSIS; URINE ACIDIFICATION; WILSON DISEASE;

ACID-BASE EQUILIBRIUM; ACIDOSIS; ALKALOSIS; ANIMALS; HUMANS; LIVER DISEASES; POTASSIUM; POTASSIUM DEFICIENCY; PROGNOSIS;

EID: 33846599407     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2006.11.001     Document Type: Article

References (49)

1. Better O.S. Renal and cardiovascular dysfunction in liver disease. Kidney Int 29 (1986) 598-607
2. Cooperman M.T., Davidoff F., Spark R., et al. Clinical studies of alcoholic ketoacidosis. Diabetes 23 (1974) 433-439
3. Funk G.C., Doberer D., Osterreicher C., et al. Equilibrium of acidifying and alkalinizing metabolic acid-base disorders in cirrhosis. Liver Int 25 (2005) 505-512
4. Gabduzda G.J., and Hall P.W. Relation of potassium depletion to renal ammonium metabolism and hepatic coma. Medicine (Baltimore) 45 (1966) 481-490
5. Gabow P.A., Moore S., and Schrier R.W. Spironolactone-induced hyperchloremic acidosis in cirrhosis. Ann Intern Med 90 (1979) 338-340
6. Golding P.L. Renal tubular acidosis in chronic liver disease. Postgrad Med J 51 (1975) 550-556
7. Golding P.L., and Mason A.S. Renal tubular acidosis and autoimmune liver disease. Gut 12 (1971) 153-157
8. Goodkin D.A., Krishna G.G., and Narins R.G. The role of the anion gap in detecting and managing mixed metabolic acid-base disorders. Clin Endocrinol Metab 13 (1984) 333-349
9. Kee C.S., Choi J.W., Chang D.K., et al. Hyperkalemia due to hyporeninemic hypoaldosteronism with liver cirrhosis and hypertension. J Korean Med Sci 8 (1993) 464-470
10. Moreau R., Hadengue A., Soupison T., et al. Arterial and mixed venous acid-base status in patients with cirrhosis. Influence of liver failure. Liver 13 (1993) 20-24
11. Mulhausen R., Eichenholz A., and Blumentals A. Acid-base disturbances in patients with cirrhosis of the liver. Medicine (Baltimore) 46 (1967) 185-189
12. Pares A., Rimola A., Bruguera M., et al. Renal tubular acidosis in primary biliary cirrhosis. Gastroenterology 80 (1981) 681-686
13. Prytz H., and Thomsen A.C. Acid-base status in liver cirrhosis. Disturbances in stable, terminal and portal-caval shunted patients. Scand J Gastroenterol 11 (1976) 249-256
14. Record C.O., Iles R.A., Cohen R.D., et al. Acid-base and metabolic disturbances in fulminant hepatic failure. Gut 16 (1975) 144-149
15. Roberts K.E., Vanamee P., Poppell J.W., et al. Electrolyte alterations in liver disease and hepatic coma. Med Clin North Am 40 (1956) 901-914
16. Zavagli G., Ricci G., Bader G., et al. The importance of the highest normokalemia in the treatment of early hepatic encephalopathy. Miner Electrolyte Metab 19 (1993) 362-367
17. Cardenas A., and Arroyo V. Mechanisms of water and sodium retention in cirrhosis and the pathogenesis of ascites. Best Pract Res Clin Endocrinol Metab 17 (2003) 607-622
18. Epstein M., Berk D.P., Hollenberg N.K., et al. Renal failure in the patient with cirrhosis. The role of active vasoconstriction. Am J Med 49 (1970) 175-185
19. Wilkinson S.P. The kidney and liver diseases. J Clin Pathol 34 (1981) 1241-1244
20. Wilkinson S.P., Hirst D., Day D.W., et al. Spectrum of renal tubular damage in renal failure secondary to cirrhosis and fulminant hepatic failure. J Clin Pathol 31 (1978) 101-107
21. Akriviadis E.A., Ervin M.G., Cominelli F., et al. Hyponatremia of cirrhosis: Role of vasopressin and decreased 'effective' plasma volume. Scand J Gastroenterol 32 (1997) 829-834
22. Epstein M., Levinson R., Sancho J., et al. Characterization of the renin-aldosterone system in decompensated cirrhosis. Circ Res 41 (1977) 818-829
23. Tulassay T., Tulassay Z., and Rascher W. Atrial natriuretic peptide in patients with decompensated hepatic cirrhosis. Gastroenterol J 50 (1990) 140-143
24. Cardenas A., and Arroyo V. Refractory ascites. Dig Dis 23 (2005) 30-38
25. Gines A., Escorsell A., Gines P., et al. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology 105 (1993) 229-236
26. Shear L., Bonkowsky H.L., and Gabuzda G.J. Renal tubular acidosis in cirrhosis. A determinant of susceptibility to recurrent hepatic precoma. N Engl J Med 280 (1969) 1-7
27. Krapf R., Beeler I., Hertner D., et al. Chronic respiratory alkalosis. The effect of sustained hyperventilation on renal regulation of acid-base equilibrium. N Engl J Med 324 (1991) 1394-1401
28. Lustik S.J., Chhibber A.K., Kolano J.W., et al. The hyperventilation of cirrhosis: Progesterone and estradiol effects. Hepatology 25 (1997) 55-58
29. Eiseman B., and Clark G.M. Studies in ammonia metabolism. III. The experimental production of coma by carotid arterial infusion of ammonium salts. Surgery 43 (1958) 476-485
30. Haussinger D., Steeb R., and Gerok W. Metabolic alkalosis as driving force for urea synthesis in liver disease: Pathogenetic model and therapeutic implications. Clin Invest 70 (1992) 411-415
31. McAuliffe J.J., Lind L.J., Leith D.E., et al. Hypoproteinemic alkalosis. Am J Med 81 (1986) 86-90
32. Shangraw R.E., and Jahoor F. Effect of liver disease and transplantation on urea synthesis in humans: Relationship to acid-base status. Am J Physiol 276 (1999) G1145-G1152
33. Oster J.R., Hotchkiss J.L., Carbon M., et al. Abnormal renal acidification in alcoholic liver disease. J Lab Clin Med 85 (1975) 987-1000
34. Davidson B.K., and Haslock I. Osteomalacia secondary to renal tubular acidosis masquerading as primary biliary cirrhosis. Rheumatology (Oxford) 39 (2000) 1428-1429
35. Kodama T., Imai H., Wakui H., et al. Tubulointerstitial nephritis with renal tubular acidosis and asymptomatic primary biliary cirrhosis accompanied by antibody to a 52-kDa mitochondrial protein alone. Clin Nephrol 45 (1996) 401-405
36. Tsantoulas D.C., McFarlane I.G., Portmann B., et al. Cell-mediated immunity to human Tamm-Horsfall glycoprotein in autoimmune liver disease with renal tubular acidosis. BMJ 4 (1974) 491-494
37. Batlle D.C., Hizon M., Cohen E., et al. The use of the urinary anion gap in the diagnosis of hyperchloremic metabolic acidosis. N Engl J Med 318 (1988) 594-599
38. Batlle D.C., von Riotte A., and Schlueter W. Urinary sodium in the evaluation of hyperchloremic metabolic acidosis. N Engl J Med 316 (1987) 140-144
39. Batlle D. Hyperchloremic metabolic acidosis. In: Seldin D.W., and Giebisch G. (Eds). The Regulation of Acid-Base Balance (1989), Raven Press, New York 319-351
40. Anderson R. Electrolyte, water, mineral, and acid-base disorders in liver disease. In: Narins R. (Ed). Clinical Disorders of Fluid and Electrolyte Metabolism (1994), McGraw Hill, New York 1153-1172
41. Lino M., Binaut R., Noel L.H., et al. Tubulointerstitial nephritis and Fanconi syndrome in primary biliary cirrhosis. Am J Kidney Dis 46 (2005) e41-e46
42. Leeson P.M., and Fourman P. A disorder of copper metabolism treated with penicillamine in a patient with primary biliary cirrhosis and renal tubular acidosis. Am J Med 43 (1967) 620-635
43. Casey T.H., Summerskill W.H., Bickford R.G., et al. Body and serum potassium in liver disease. II. Relationships to arterial ammonia, blood pH, and hepatic coma. Gastroenterology 48 (1965) 208-215
44. Casey T.H., Summerskill W.H., and Orvis A.L. Body and serum potassium in liver disease. I. Relationship to hepatic function and associated factors. Gastroenterology 48 (1965) 198-207
45. Read A.E., Laidlaw J., Haslam R.M., et al. Neuropsychiatric complications following chlorothiazide therapy in patients with hepatic cirrhosis: Possible relation to hypokalaemia. Clin Sci 18 (1959) 409-423
46. Isaac G., and Holland O.B. Drug-induced hypokalaemia. A cause for concern. Drugs Aging 2 (1992) 35-41
47. Laffi G., La Villa G., Carloni V., et al. Loop diuretic therapy in liver cirrhosis with ascites. J Cardiovasc Pharmacol 22 suppl 3 (1993) S51-S58
48. Stephan F., and Paillard F. Terlipressin-exacerbated hypokalaemia. Lancet 351 (1998) 1249-1250
49. Siamopoulos K.C., Elisaf M., and Katopodis K. Iatrogenic hyperkalaemia-points to consider in diagnosis and management. Nephrol Dial Transplant 13 (1998) 2402-2406